WASHINGTON—Following years of research and testing, the U.S. Food and Drug Administration officially approved a groundbreaking artificial tumor Tuesday, marking the first time a synthetic malignant growth has been cleared for use in patients across the country. “There were obviously significant complications in devising a tumor substitute the human body would accept, but we now have an artificial neoplasm that serves the same physiological functions as an organic abnormal growth of tissue,” said Jeffrey Shuren of the FDA’s Center for Devices and Radiological Health, adding that the polymer-based lump can be safely implanted in patients regardless of age, health, or medical history during a minimally invasive and relatively quick two-hour surgical procedure. “This synthetic tumor is remarkably lightweight, malignant, and capable of naturally metastasizing throughout the body. It also has the benefit of being incredibly small—roughly the size of a dime—but once in the body, it will grow two to three times in size and will get to work immediately replicating itself.” Shuren added that while initial prototypes of the device had only enough battery power to last a few days, the approved version is capable of going for several years or more, or until its objective has been completed.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves new breakthrough therapy for cystic fibrosisWe are excited about this new therapy for CF. By maximizing detection across ethnicities for serious heritable conditions like CF, Foresight helps couples identify risk early so they can plan and prepare. Learn more about Foresight:
Read more »
FDA panel recommends withdrawing approval of Makena drug, used to prevent preterm birthsA committee for the US Food and Drug Administration now recommends that the approval of Makena, a drug used to reduce the risk of preterm births, should be withdrawn — and some women who have used the medication are sounding the alarm
Read more »
FDA issues Halloween warning: Decorative contact lenses can cause blindness, infection, cornea scratches'Wouldn't it be cool to have vampire eyes for Halloween? Or deep violet eyes to match your purple sweater? How about your favorite sports team's logo on your eyes just for fun?' the FDA warning begins.
Read more »
Cramer: This biotech stock could be worth over $100 billion on an FDA approvalBiogen, with a $54.1 billion market cap, 'could be worth twice that if all goes well' with regulators, Jim Cramer says.
Read more »
Calm down, doggy. FDA approves generic drug for separation anxietyThe medication is for pups who fear being left alone.
Read more »
Congress, grappling with tainted Chinese drugs, is baffled by the lack of FDA oversight in the U.S. pharmaceutical supply chainFollowing major recalls of Chinese-manufactured medication that contained carcinogenic ingredients, lawmakers expressed their alarm, and sometimes disbelief, at the FDA's inability to regulate foreign suppliers at a Tuesday hearing.
Read more »